International Tech Times
SEE OTHER BRANDS

Your science and technology news reporter

International Tech Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on International Tech Times.

Press releases published on May 8, 2025

NKGen Biotech Chairman & CEO Paul Y. Song, M.D., Personally Invests $2.65 Million Cash to Accelerate Phase 2 Clinical Trial and Fulfill Financial Reporting Obligations

NKGen Biotech Chairman & CEO Paul Y. Song, M.D., Personally Invests $2.65 Million Cash to Accelerate Phase 2 Clinical Trial and Fulfill Financial Reporting Obligations

New funding from Dr. Song augments $3.0 million in funding advances from AlpineBrook Capital in 2025 above and beyond the $5.5 million proceeds and additional $4 million commitments in previously-disclosed AlpineBrook convertible notes. SANTA ANA, Calif., …

IMUNON Announces First Site Initiated for Pivotal Phase 3 OVATION 3 Study of IMNN-001 in Newly Diagnosed Advanced Ovarian Cancer

IMUNON Announces First Site Initiated for Pivotal Phase 3 OVATION 3 Study of IMNN-001 in Newly Diagnosed Advanced Ovarian Cancer

Company currently initiating additional trial sites and working with study investigators to enroll participants IMNN-001 is the first and only immunotherapy to show meaningful overall survival benefit in a Phase 2 trial in women with advanced ovarian …

Arcadia Biosciences (RKDA) Announces First Quarter 2025 Financial Results and Business Highlights

Arcadia Biosciences (RKDA) Announces First Quarter 2025 Financial Results and Business Highlights

-- Revenues increase 22% year over year driven by 90% growth in Zola® -- -- Arcadia sells patents for $750K and eliminates $1M in liabilities -- -- Roosevelt agreement amended to provide greater certainty regarding exchange ratio -- DALLAS, May 08, 2025 ( …

The Oncology Institute to Present at Upcoming ASCO Annual Meeting on High-Value Cancer Care Model Outcomes Showing Cost Savings and Lower Hospitalization Rates

The Oncology Institute to Present at Upcoming ASCO Annual Meeting on High-Value Cancer Care Model Outcomes Showing Cost Savings and Lower Hospitalization Rates

CERRITOS, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI)(“TOI”), one of the largest value-based oncology groups in the United States, announced today that it has been selected to present an abstract at the upcoming ASCO …

UK Online Shoppers Can Try on Their Next Fashion Purchase Using a 3D Avatar

UK Online Shoppers Can Try on Their Next Fashion Purchase Using a 3D Avatar

LONDON, May 08, 2025 (GLOBE NEWSWIRE) -- Online sizing technology provider, Makip, today announces a significant upgrade to its Unisize sizing recommendation engine. Using Unisize, online shoppers will now be presented with a 3D avatar of their unique body …

U.S. Online Shoppers Can Try on Their Next Fashion Purchase Using a 3D Avatar

U.S. Online Shoppers Can Try on Their Next Fashion Purchase Using a 3D Avatar

NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Online sizing technology provider, Makip, today announces a significant upgrade to its Unisize sizing recommendation engine. Using Unisize, online shoppers will now be presented with a 3D avatar of their unique …

TEN Launches First-Ever Fully On-Chain Poker Powered by Autonomous AI Agents

TEN Launches First-Ever Fully On-Chain Poker Powered by Autonomous AI Agents

- The launch of House of TEN introduces a new Web3 vertical with AI-native iGaming. Built on TEN’s encrypted Layer 2, it unlocks fully autonomous gameplay with programmable privacy, on-chain randomness, and zero off-chain logic. LONDON, May 08, 2025 (GLOBE …

BairesDev Wins Stevie Awards for AI Innovation, Executive Leadership, and Talent Development

BairesDev Wins Stevie Awards for AI Innovation, Executive Leadership, and Talent Development

MOUNTAIN VIEW, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- BairesDev®, an award-winning nearshore software development company, has been recognized with three Silver Stevie® Awards at the 23rd Annual American Business Awards®, celebrating the company’s …

Aligos Therapeutics Presents Positive Data at the EASL Congress 2025

Aligos Therapeutics Presents Positive Data at the EASL Congress 2025

SOUTH SAN FRANCISCO, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today …

OUPES Launches Exodus 2400: Affordable Power for Emergencies, Adventures, and Everyday Resilience

OUPES Launches Exodus 2400: Affordable Power for Emergencies, Adventures, and Everyday Resilience

NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- With Memorial Day just weeks away, OUPES, a leader in sustainable energy innovation, today unveiled the Exodus 2400, a portable power station that is designed to power summer camping trips, backyard gatherings, …

PDS Biotech Announces Additional Details on Two Preclinical Universal Influenza Presentations at IMMUNOLOGY2025™ Annual Meeting

PDS Biotech Announces Additional Details on Two Preclinical Universal Influenza Presentations at IMMUNOLOGY2025™ Annual Meeting

PRINCETON, N.J., May 08, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers and infectious …

Artiva Biotherapeutics Reports First Quarter 2025 Financial Results, Recent Business Highlights

Artiva Biotherapeutics Reports First Quarter 2025 Financial Results, Recent Business Highlights

IND clearance and initiation of global basket trial exploring AlloNK® + rituximab in refractory rheumatoid arthritis, Sjögren’s disease, idiopathic inflammatory myopathies and systemic sclerosis First trial to explore an allogeneic cell therapy in …

Blue Mantis Expands Leadership Team to Drive Growth, Innovation and Market Impact

Blue Mantis Expands Leadership Team to Drive Growth, Innovation and Market Impact

PORTSMOUTH, N.H., May 08, 2025 (GLOBE NEWSWIRE) -- Blue Mantis, a leading provider of digital strategy and services specializing in managed services, cybersecurity and cloud solutions, today announced the appointments of Ruya Barrett as Chief Marketing …

ORYZON Awarded €13.26 Million Through the First Important Project of Common European Interest (IPCEI) in the Health Sector (Med4Cure Project)

ORYZON Awarded €13.26 Million Through the First Important Project of Common European Interest (IPCEI) in the Health Sector (Med4Cure Project)

Approximately 15 million USD Oryzon to validate epigenetic agents by applying a personalized medicine approach for rare and orphan diseases Oryzon will explore Aggression in specific subsets of Autism Spectrum Disorder (ASD) to expand the precision …

Pathos AI Appoints Iker Huerga as Chief Executive Officer to Lead the Next Era of AI-Enabled Drug Development

Pathos AI Appoints Iker Huerga as Chief Executive Officer to Lead the Next Era of AI-Enabled Drug Development

NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Pathos AI, a leading AI-enabled biotech company focused on transforming drug development in oncology, today announced the appointment of Iker Huerga as Chief Executive Officer and Board Member. Huerga brings over …

NV5 Awards 2025 National Society of Black Engineers Scholarships

NV5 Awards 2025 National Society of Black Engineers Scholarships

HOLLYWOOD, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- NV5, a provider of tech-enabled engineering, certification, and consulting solutions, announced today the winners of the 2025 NV5 National Society of Black Engineers (NSBE) scholarship awards. This year's …

NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results

NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results

– EMA submission expected in 2H25 by partner Menarini – – PREVAIL Phase 3 CVOT remains on track – -- BROADWAY and TANDEM results presented at EAS with simultaneous publications in the New England Journal of Medicine and The Lancet, respectively -- -- …

D-BOX and Cinemark Announce Expansion with the Addition of Over 70 New D-BOX Haptic-Enabled Screens

D-BOX and Cinemark Announce Expansion with the Addition of Over 70 New D-BOX Haptic-Enabled Screens

MONTREAL, May 08, 2025 (GLOBE NEWSWIRE) -- D-BOX Technologies Inc. (“D-BOX” or the "Corporation") (TSX: DBO), a Corporation with more than 25 years of experience creating haptic and immersive experiences, is proud to announce an expansion of its long- …

D-BOX et Cinemark annoncent une expansion avec l’ajout de plus de 70 nouvelles salles équipées de la technologie haptique D-BOX

D-BOX et Cinemark annoncent une expansion avec l’ajout de plus de 70 nouvelles salles équipées de la technologie haptique D-BOX

MONTRÉAL, 08 mai 2025 (GLOBE NEWSWIRE) -- Technologies D-BOX inc. (« D-BOX » ou la « Société ») (TSX : DBO), une entreprise comptant plus de 25 ans d’expérience dans la création d’expériences haptiques et immersives, est fière d’annoncer une nouvelle phase …

Merus to Present at BofA Securities 2025 Health Care Conference

Merus to Present at BofA Securities 2025 Health Care Conference

UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), an oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced that Bill Lundberg, M.D …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service